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CME ARTICLE
Skin Biopsy in Netherton Syndrome: A Histological Review
of a Large Series and New Findings
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Abstract: Netherton syndrome (NS) is a severe genetic skin
disorder, with often delayed or misleading clinical signs. The
histological features of skin biopsies, usually described as a psoriasi-
form hyperplasia, have only been reported in isolated case reports or
small case series. The aim of this study is to deﬁne, for the ﬁrst time,
the precise histological pattern of cutaneous lesions, in a large cohort
of skin biopsies from conﬁrmed NS patients. The study included 80
consecutive skin biopsies from 67 patients taken between January
1995 and June 2014. All were from conﬁrmed NS patients with
either a negative lympho-epithelial Kazal-type–related inhibitor
(LEKTI) immunohistochemistry and/or molecular conﬁrmation by
identiﬁed mutation in SPINK5. In this cohort, the most frequent
histological ﬁnding was also psoriasiform hyperplasia, but there
were additional, less common, or previously unreported ﬁndings,
including compact parakeratosis with large nuclei, subcorneum or
intracorneum splitting, presence of clear cells in the upper epidermis
or stratum corneum, dyskeratosis, dermal inﬁltrate with neutrophils
and/or eosinophils, and dilated blood vessels in the superﬁcial der-
mis. An early conﬁrmation of the diagnosis of NS is essential for
improved patient management. Thus, in the situation of a patient
with an unknown skin disorder and non speciﬁc clinical presentation,
the dermatopathologist may now be able to suggest the diagnosis of
NS based on these newly reported characteristics. However, LEKTI
immunohistochemistry remains the essential diagnostic investigation
in cases with misleading or nonspeciﬁc histological features and is
mandatory for the deﬁnitive diagnosis of NS in all patients.
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LEARNING OBJECTIVES
At the completion of this CME, the reader will be
able to:
1. Provide a diagnosis of Netherton Syndrome in babies with
erythroderma or an unknown skin disorder thought to be
a disorder of corniﬁcation
2. Suggest the diagnosis of Netherton Syndrome based on
newly reported characteristics
3. Describe the speciﬁc immunohistochemical staining seen
in Netherton Syndrome and know to send a parafﬁn-ﬁxed
biopsy to a reference center.
INTRODUCTION
Netherton syndrome (NS, OMIM 256500) is a rare
autosomal recessive genodermatosis. It is characterized by the
triad of linear circumﬂex ichthyosis (Fig. 1A), trichorrhexis
invaginata of hair and eyebrows, and atopic manifestations
with high IgE levels in the serum. However, the onset of these
typical clinical manifestations may be delayed and the clinical
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features misleading. In infants, the disorder can present with
severe and life-threatening erythroderma (Fig. 1B). In such
cases, as well as in atypical adult cases, the diagnosis is
challenging1,2 and skin biopsy is mandatory.
The histological features seen in skin biopsies from NS
patients, usually described as a psoriasiform hyperplasia, have
only been reported in isolated case descriptions or small case
series.3–5 The aim of this study is to deﬁne the histological
pattern of cutaneous lesions precisely and in a large cohort of
skin biopsies from conﬁrmed NS patients.
MATERIAL AND METHODS
This study included 80 consecutive skin biopsies from
67 NS patients analyzed retrospectively between January
1995 and June 2012 and prospectively from June 2012 until
June 2014. All cases were collected from the informatics
database of the Department of Pathology at Necker-Enfants
Malades Hospital. Patients were either managed in our
hospital or followed in other institutions with the skin
samples provided to us for diagnostic conﬁrmation.
Only skin biopsies with either negative lympho-epithelial
Kazal-type–related inhibitor (LEKTI) immunohistochemistry
(IHC) and/or a molecular conﬁrmation of NS were included.
LEKTI is a serine protease inhibitor encoded by serine protease
inhibitor Kazal-type 5 (SPINK5), the causative gene of the
NS.6,7 For cases before 2000, LEKTI IHC was performed ret-
rospectively. LEKTI was considered negative if the granular
layer and/or inner root sheath of hair follicles were totally neg-
ative compared with a positive skin control (independently eval-
uated by 2 dermatopathologists, S.L.-M. and S.F.).
For histological analysis, skin biopsy specimens were
ﬁxed in 10% formalin, embedded in parafﬁn, divided into
3-mm-thick sections, and stained with hematoxylin, eosin,
and saffron, and periodic acid–Schiff (PAS). IHC on skin
biopsies, from 2000 to 2013, was performed using a mono-
clonal antibody against the D1–D6 domains of LEKTI
(provided by Alain Hovnanian’s laboratory) with a classical
3-step immunoperoxidase technique on formalin-ﬁxed paraf-
ﬁn-embedded sections.7 For biopsies from 2013 to 2014, we
used a commercially available monoclonal antibody (clone
SC48756). After deparafﬁnization, reactions were performed
according to the automated system (A. Menarini Diagnosis
system, Firenze, Italy) (Table 1). Staining was performed with
the Bond polymer reﬁne detection kit.
Each slide was examined retrospectively by 2 indepen-
dent dermatopathologists (S.L.-M. and S.F.), and the follow-
ing data were collected: pattern of the epidermal hyperplasia
(psoriasiform, ichthyosiform, eczematiform, nonspeciﬁc),
stratum corneum (present/absent, thickness, splitting, para-
keratosis/orthokeratosis, microabcesses), stratum granulosum
FIGURE 1. Collection by C. Bod-
emer: (A) infant with NS: typical
aspect of linear circumflex ich-
thyosis; (B) infant with NS: congen-
ital erythroderma.
TABLE 1. Methods for Immunohistochemistry With the
Automatized System Bond, A. Menarini Diagnosis System
Pretreatment
Duration,
min Dilution
Incubation,
min
HPV antibody ER1 30 1/2000 20
LEKTI
antibody
ER2 20 1/250 20
TABLE 2. Histological Aspects of the 80 Examined Biopsies
Epidermal Changes n (%)
Stratum corneum
Absent 10 (12.5)
Split 46 (57.6)
Parakeratosic 65 (81.3)
Orthokeratosic 36 (45.0)
Microabcesses 21 (26.3)
Granular layer
Normal or increased 38 (47.5)
Decreased 56 (70.0)
Absent 48 (60.0)
Clear cells 5 (6.3)
Spinous layer
Spongiosis 7 (8.7)
Dyskeratosis 11 (13.8)
Intraepidermal exocytosis 5 (6.3)
Hyperplasia
Psoriasiform 69 (86.3)
Not speciﬁc 20 (25.0)
Dermal Changes n (%)
Inﬂammation
Mild 59 (73.0)
Intense 17 (21.3)
Polynuclear neutrophils 19 (23.8)
Polynuclear eosinophils 26 (32.5)
Vessels
Dilatation 41 (51.3)
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(normal or increased/diminished/absent), Malpighian layer
(spongiosis, dyskeratosis), inﬂammatory cell exocytosis,
dermal inﬂammation (intensity, presence of neutrophils or
eosinophils), dilatation of superﬁcial blood vessels. An
additional IHC study with anti–human papillomavirus (anti-
HPV) antibody (Table 1) was performed in 5 cases with clear
cells in the stratum corneum.
If there was discordance between the 2 examiners
regarding the results of histology and/or IHC, the slides were
reviewed simultaneously by both examiners using a 2-headed
microscope and an agreement was reached.
RESULTS
Overall, 80 skin biopsies from 67 patients were
included in the study. The patients’ age ranged from 6 days
to 80 years, with 50% of the patients being younger than 2
years. LEKTI IHC was negative in 100% of the skin biopsies.
Molecular diagnosis was conﬁrmed by SPINK5 sequencing in
all patients who were genetically tested (51 of 67 patients).
The overall histological ﬁndings are summarized in
Table 2. Sums may be greater than 100% because several
patterns regularly coexisted in single biopsies, demonstrating
heterogeneity of the lesions within a single patient. The most
frequently observed aspect was a psoriasiform hyperplasia
with a hyperplastic epidermis and elongated regular rete
ridges. This is different from that seen in psoriasis because
of the absence of suprapapillary thinning and to the presence
of a compact parakeratosis with large nuclei. A mild, dermal
inﬂammatory inﬁltrate was often present (Fig. 2).
In addition to the psoriasiform hyperplasia, other
changes were also observed. The stratum corneum was
sometimes absent or split (Figs. 3A–C). Microabcesses were
frequently observed (Fig. 4), with negative PAS staining in
all but 1 case. Clear cells with a pseudoviral aspect (pseudo-
koilocytes, HPV staining negative) could be observed in the
stratum granulosum or stratum corneum (Figs. 5A–C). The
granular layer could be normal, absent, or diminished in
the same biopsy. We also observed the coexistence of para-
keratosis overlying an absent granular layer alternating with
orthokeratosis overlying a normal granular layer (Fig. 6).
In 2 cases, the features were similar to those seen in
autosomal recessive congenital ichthyosis, speciﬁcally com-
pact hyperorthokeratosis with a thick granular layer and
hyperplasic epidermis (Fig. 7).
Spongiosis was unusual (Fig. 8) while dyskeratosis was
found in some cases.
Dermal inﬂammation was often mild but sometimes
conspicuous (Fig. 9). When inﬂammatory cells were present,
prominence of eosinophils was observed in almost a third of
the cases, with or without epidermal exocytosis (Fig. 10A). In
addition, dermal neutrophils were often observed, sometimes
in a large number, with epidermal exocytosis and microab-
cesses (Fig. 10B). In some patients, histology revealed only
FIGURE 2. “Common” histological findings in Netherton syndrome. A, Hematein Eosin Saffron, ·200 magnification: compact
parakeratosis (arrow), large nuclei, regular elongation of the rete ridges, absence of suprapapillary thinning; (B) LEKTI in normal
skin, ·100; (C) LEKTI is negative in NS patient’s skin, ·200 magnification.
FIGURE 3. A, Hematein Eosin Saffron, ·200 magnification: complete splitting of the stratum corneum; (B) Hematein Eosin Saffron,
·200 magnification: splitting in multiple layers; (C) Hematein Eosin Saffron, ·400 magnification: pseudo-vesiculosus splitting.
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mild abnormalities such as a subtle splitting of a basket-
weave stratum corneum (Fig. 11).
DISCUSSION
To our knowledge, this series, with 80 skin biopsies
from 67 patients, is the largest study to report the histological
patterns of NS. We conﬁrm the high frequency of psoriasi-
form hyperplasia and describe previously unreported
characteristics.
The clinical diagnosis of NS is difﬁcult to make and often
delayed, because the clinical triad of linear circumﬂex ichthyo-
sis, trichorrhexis invaginata of hair and eyebrows, and atopic
manifestations, which characterized NS in its ﬁrst descriptions,
are not always present. In addition, the typical hair shaft
anomaly is exceptionally seen before the ﬁrst year. The disease
can be severe, and potentially life-threatening, with the occur-
rence of hypernatremic dehydration, seizures, diarrhea, and
recurrent sepsis.2 An early skin biopsy is very helpful in making
the diagnosis, and we have reported 100% sensitivity and spec-
iﬁcity in distinguishing NS from other conditions, mostly immu-
nodeﬁciency syndromes, in neonatal and infantile erythroderma
since LEKTI antibodies became available in 2000.8
For adults, linear circumﬂex ichthyosis may be easily
recognized and hair shaft or eyebrow examination (dermo-
scopy9 or light microscopy10) is useful as trichorrhexis inva-
ginata is speciﬁc to NS. However, NS can also have unusual
clinical features, such as atypical, chronic atopic dermatitis, or
a nonspeciﬁc ichthyotic pattern. In all these cases, a skin
biopsy is essential to make the correct diagnosis.
The largest series that includes morphologic descrip-
tions of NS was published by Hausser and Anton-Lanprecht3
and described 19 cases with seborrheic or psoriasiform der-
matitis, parakeratosis, and the lack of a granular layer. This
psoriasiform hyperplasia was also seen in most of our cases
(86.3%). In addition, splitting of the subcorneum was often
present in our skin samples, and, in some cases, the stratum
corneum was totally absent.
Splitting of the subcorneum is biologically consistent, as
SPINK5 knockout mice display superﬁcial peeling caused by
stratum corneum detachment from the granular layer, and links
this morphologic aspect to the causative genetic defect.11
Furthermore, a recent review reported the overlap between 3
skin conditions in which cell–cell adhesion is impaired and
stratum corneum detachment occurs, namely severe dermatitis–
multiple allergies–metabolic wasting syndrome, type B peeling
skin disease, and NS.12 Such detachment of the stratum corneum
was ﬁrst reported by Comel,13 and although splitting has been
well described in studies using electron microscopy,2,3,11 it is
rarely reported using light microscopy.
Thus, despite being nonspeciﬁc, subcorneum splitting
may be a helpful sign to look for by light microscopy.
A psoriasiform hyperplasia was often observed in our
cases, but no suprapapillary thinning, as is seen in psoriasis,
was noted. In our experience, spongiosis was uncommon,
occurring in less than 10% of cases. This is in contrast to
other authors who reported that spongiosis could be pro-
nounced in the lower epidermal cell layers.2
FIGURE 4. Hematein Eosin Saffron, ·400 magnification:
multilocular microabcesses in the stratum corneum.
FIGURE 5. A, Hematein Eosin Saffron, ·400 magnification: clear cells in the stratum corneum (arrow); (B) Hematein Eosin Saffron,
·200 magnification: clear pseudo-koilocytic cells in the stratum granulosum (arrow); (C) Hematein Eosin Saffron, ·200 magnifi-
cation: clear cells in the upper spinous layer (arrow). See also spongiosis, rarely observed in our series. HPV immunochemistry was
negative in these 5 cases.
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In our series, we found that parakeratosis in NS is
compact and shows large nuclei that is very different from
psoriatic parakeratosis. Ong and Harper2 described that the
outermost nucleated cell layer does not appear to ﬂatten nor-
mally. Similar ﬁndings, that is, a psoriasiform pattern with
mild, perivascular inﬂammatory inﬁltrate in the superﬁcial der-
mis, were described by Weedon4 and Metze.5 Biopsies from
the center of the lesions were reported to show aspects of
atopic dermatitis rather than psoriasiform features.5 We were
unable to conﬁrm this observation as our skin biopsies were
either taken at scaly margins or from areas without speciﬁc
information. No correlation could be established between the
type of inﬂammatory cells (neutrophils or eosinophils) and the
aspect of the epidermis (psoriasiform or spongiotic).
In our series, the inﬂammation was usually moderate
and both neutrophils and eosinophils were commonly
observed. PAS was always negative. In common inﬂamma-
tory skin diseases, the inﬂammatory inﬁltrates are more
frequently composed of histiocytes and lymphocytes. The
presence of a predominent eosinophilic inﬁltrate in one of our
3 cases, rarely reported before, may be explained by the
secretion of speciﬁc chemotactic mediators in direct relation
with the atopic diathesis of NS. In the series of Hausser and
Anton-Lanprecht,3 a variable dermal inﬂammatory inﬁltrate
was described, with various cells including neutrophils asso-
ciated with subsequent formation of small, intraepidermal,
mostly superﬁcial pustules or microabcesses.
In addition to the above, we observed several new
histological anomalies. First was the presence of dyskeratotic
cells, with no more than 1 to 3 cells that were always located
in the upper spinous layer. This is not easily explained by the
pathophysiology of NS and could be related to the use of
topical products.
FIGURE 6. Hematein Eosin Saffron, ·200 magnification:
coexistence of parakeratosis (arrow) overlying an absent
granular layer alternating with orthokeratosis (double arrow)
and normal granular layer.
FIGURE 7. Hematein Eosin Saffron, ·200 magnification: NS
with an aspect of autosomal recessive congenital ichthyosis
(compact hyperorthokeratosis, thick granular layer, and hyper-
plastic epidermis).
FIGURE 8. Hematein Eosin Saffron, ·200 magnification:
spongiosis.
FIGURE 9. Hematein Eosin Saffron, ·50 magnification: marked
superficial and middermal perivascular infiltrate.
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Second, we noted the presence of dilated blood vessels
in the upper dermis in more than 50% of our cases. This may
correlate with the degree of erythema and/or erythroderma.
However, the histological aspects can be misleading, may
mimick other conditions such as autosomal recessive con-
genital ichthyosis, or be entirely nonspeciﬁc.
The use of IHC with LEKTI-speciﬁc antibodies to
demonstrate the absence of the protein in the epidermis (Fig.
3C) allows for the deﬁnitive diagnosis of NS.7,8,14,15 In normal
skin, LEKTI IHC is always positive in the granular layer and
the inner root sheath of hair follicles (Fig. 3B). One hundred
percent of the cases in our series were LEKTI negative. A
deﬁnitive diagnosis of NS requires LEKTI negativity within
the inner root sheath of the follicular ostia, because the gran-
ular layer may be missing in both NS and other conditions.
NS is a severe genetic skin disorder with a heterogeneous
clinical presentation that can be misleading and delay accurate
diagnosis. Early conﬁrmation of the diagnosis is essential for
proper patient management. Thus, a skin biopsy is mandatory if
typical hair shaft anomalies are not found. In this study, we show
that the histological features of NS are not restricted to the
classically described “psoriasiform aspect,” and additional histo-
logical characteristics can be helpful in correctly making the
diagnosis. Compact parakeratosis with large nuclei, subcorneum
or intracorneum splitting, absence of stratum corneum, frequent
microabcesses (PAS negative), elongated rete ridges without
suprapapillary thinning, dermal inﬁltrates rich in neutrophils
and/or eosinophils, and dilated blood vessels in the superﬁcial
dermis are all seen in NS and, especially when seen in combina-
tion, can aid correct diagnosis. For patients with an unknown skin
disorder and a nonspeciﬁc clinical presentation, the dermatopa-
thologist may now be able to propose a diagnosis of NS based on
light microscopy. However, performing LEKTI staining remains
mandatory for the deﬁnitive diagnosis of NS in all patients.
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FIGURE 10. A, Hematein Eosin Saffron, ·400
magnification: numerous dermal and intra-
epidermal eosinophils. B, Hematein Eosin Saffron,
·200 magnification: numerous dermal and intra-
epidermal neutrophils and eosinophils, intra-
epidermal exocytosis.
FIGURE 11. Hematein Eosin Saffron, ·200 magnification:
subnormal skin biopsy, with a subtle splitting (arrows) of
a basket-weave stratum corneum.
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Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Lippincott Continuing Medical Education Institute, Inc., designates this journal-based CME activity for a maximum of one
(1) AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in
the activity.
To earn CME credit, you must read the article in The American Journal of Dermatopathology and complete the quiz,
answering at least 80 percent of the questions correctly. Mail the Answer Sheet along with a check or money order for the
$15 processing fee, to Lippincott CME Institute, Inc., Wolters Kluwer Health, Two Commerce Square, 2001 Market Street,
3rd Floor, Philadelphia, PA 19103. Only the ﬁrst entry will be considered for credit, and must be postmarked by the
expiration date. Answer sheets will be graded and certiﬁcates will be mailed to each participant within 6 to 8 weeks of
participation.
CME EXAMINATION
February 2016
Please mark your answers on the ANSWER SHEET.
At the completion of this CME, the reader will be able to provide a diagnosis of Netherton Syndrome in babies with
erythroderma or an unknown skin disorder thought to be a disorder of corniﬁcation, suggest the diagnosis of Netherton
Syndrome based on newly reported characteristics and describe the speciﬁc immunohistochemical staining seen in Netherton
Syndrome and know to send a parafﬁn-ﬁxed biopsy to a reference center.
1. The gene implicated in Netherton syndrome (NS) is:
A. LEKTI
B. TGM5
C. SPINK5
D. ABCA12
2. NS is characterized by a clinical triad of:
A. Erythroderma, photophobia, trichorrhexis nodosa
B. Linear circumﬂex ichthyosis, trichorrhexis invaginata, atopic manifestations
C. Psoriasis, pili torti, diarrhea
D. Linear circumﬂex ichthyosis, xerostomia, pili canaliculi
3. Which of the following is not true concerning NS?
A. Histology often demonstrates eczematiform lesions
B. Sub-corneal splitting is frequently observed
C. Mast cells are numerous in the dermal inﬁltrate
D. The parakeratosis is compact
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4. Potentially misleading histological ﬁndings in NS that can mimic other genodermatoses include:
A. Autosomal recessive ichthyosis
B. Epidermolytic ichthyosis
C. Erythrokeratoderma Variabilis
D. Hailey–Hailey disease
5. A histological diagnosis of NS requires:
A. A formalin-ﬁxed biopsy for standard histology and a frozen biopsy for immunohistochemistry with LEKTI antibody
B. A formalin-ﬁxed biopsy for standard histology and a blood sample for indirect immunoﬂuorescence with LEKTI antibody
C. A formalin-ﬁxed biopsy for standard histology and immunohistochemistry with LEKTI antibody
D. A frozen biopsy for immunohistochemistry with LEKTI antibody only, standard histology is not helpful.
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